Journal of Medicinal Chemistry p. 3098 - 3105 (1991)
Update date:2022-08-03
Topics:
Shepard
Graham
Hudcosky
Michelson
Scholz
Schwam
Smith
Sondey
Strohmaier
Smith
Sugrue
For several decades a tantalizing goal for the treatment of primary open-angle glaucoma has been the development of a topically active carbonic anhydrase inhibitor. Recent results from several research groups indicate that considerable progress has been made toward this objective. In this report, we present the design and synthesis of (hydroxyalkyl)sulfonyl-substituted benzene- and thiophenesulfonamides. These compounds exhibit inhibition of carbonic anhydrase II in the nanomolar range and lower intraocular pressure in the α-chymotrypsinized rabbit model of ocular hypertension after topical instillation.
View MoreNanjing Vincero International Trading Co.,Ltd
Contact:8618936897229
Address:NO.68, ZhuShan Road, JiangNing WanDa Plaza, Building E Room 1703
AstaTech ( Chengdu) BioPharmaceutical Corp.
website:http://www.astabiochem.cn/
Contact:+86-15198215156-15198215156
Address:SICHUAN CHENGDU
Contact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Contact:Tel: +86-25-58353800
Address:23 Lijing Road, Nanjing Hi-Tech Zone, Nanjing, Jiangsu, China, 210061
website:http://www.arromax.com
Contact:+86-0512-62959601 skype:aimmezhang
Address:Suite 401, Bldg A3, 218 Xinghu St.Suzhou Industrial Park 215123, P.R. China
Doi:10.1016/S0040-4039(00)92726-6
(1991)Doi:10.1016/j.tetlet.2011.12.074
(2012)Doi:10.1007/s10562-017-2127-0
(2017)Doi:10.1021/ol203332j
(2012)Doi:10.1021/jo2026977
(2012)Doi:10.1016/j.poly.2011.12.030
(2012)